Moi Univeristy   Report issue

Academic/Hospital Phase 3
Founded: Kesses Kenya (1984)

Organization Overview

First Clinical Trial
2006
NCT00562874
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Moi Univeristy | Moi University

Active Ingredients

Drugs in Phase 3 Trials (1)

azithromycin (zithromax) (1 trial)

Drugs in Other Trials (3)

artemisinin (2 trials)

human papillomavirus 9-valent vaccine, recombinant (Gardasil 9) (1 trial)

soybean (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Death (Phase 3)

Infections (Phase 3)

Maternal Death (Phase 3)

Neonatal Sepsis (Phase 3)

Perinatal Death (Phase 3)

Pregnancy Complications, Infectious (Phase 3)

Puerperal Infection (Phase 3)

Sepsis (Phase 3)

Toxemia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 4